Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 6,826Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 35PF PRISM CV

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CRIZOTINIB

US Patent Number : 7825137

Drug Substance Claim :

Drug Product Claim :

Application Number : 202570

Patent Use Code : U-3403

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-05-12

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CRIZOTINIB

US Patent Number : 7825137

Drug Substance Claim :

Drug Product Claim :

Application Number : 202570

Patent Use Code : U-3403

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-05-12

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CRIZOTINIB

US Patent Number : 7825137

Drug Substance Claim :

Drug Product Claim :

Application Number : 217581

Patent Use Code : U-3057

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-05-12

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CRIZOTINIB

US Patent Number : 7825137

Drug Substance Claim :

Drug Product Claim :

Application Number : 217581

Patent Use Code : U-3403

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-05-12

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CRIZOTINIB

US Patent Number : 7825137

Drug Substance Claim :

Drug Product Claim :

Application Number : 217581

Patent Use Code : U-3058

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-05-12

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CRIZOTINIB

US Patent Number : 7825137

Drug Substance Claim :

Drug Product Claim :

Application Number : 217581

Patent Use Code : U-3057

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-05-12

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CRIZOTINIB

US Patent Number : 7825137

Drug Substance Claim :

Drug Product Claim :

Application Number : 217581

Patent Use Code : U-3058

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-05-12

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CRIZOTINIB

US Patent Number : 7825137

Drug Substance Claim :

Drug Product Claim :

Application Number : 217581

Patent Use Code : U-3403

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-05-12

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CRIZOTINIB

US Patent Number : 7825137

Drug Substance Claim :

Drug Product Claim :

Application Number : 217581

Patent Use Code : U-3403

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-05-12

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CRIZOTINIB

US Patent Number : 7825137

Drug Substance Claim :

Drug Product Claim :

Application Number : 217581

Patent Use Code : U-3057

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-05-12

blank